Loading clinical trials...
Loading clinical trials...
Efficacy & Safety of Pharmacokinetically-Driven Dosing of Mycophenolate Mofetil for the Treatment of Pediatric Proliferative Lupus Nephritis- A Double-Blind Placebo Controlled Clinical Trial
Conditions
Interventions
Mycophenolate Mofetil
Mycophenolate Mofetil
Locations
19
United States
University of California, San Francisco
San Francisco, California, United States
Children's Hospital Colorado
Aurora, Colorado, United States
Emory Children's Center
Atlanta, Georgia, United States
Ann & Robert H. Lurie Children's Hospital of Chicago
Chicago, Illinois, United States
University of Chicago Medicine- Comer Children's
Chicago, Illinois, United States
Washington University in St. Louis School of Medicine
St Louis, Missouri, United States
Start Date
June 7, 2024
Primary Completion Date
July 1, 2026
Completion Date
January 1, 2027
Last Updated
March 18, 2026
NCT05126277
NCT07015983
NCT06947460
NCT07107659
NCT07225387
NCT05934149
Lead Sponsor
Children's Hospital Medical Center, Cincinnati
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions